Back
HFA Premium Access

Spironolactone reduces all-cause mortality in women but not men with heart failure with preserved ejection fraction enrolled in TOPCAT from the Americas

Session: Moderated Poster session 6 - Therapy
Topic: HFpEF - Heart failure with preserved ejection fraction
Speaker: Associate Professor D. Kao (Aurora, US)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Associate Professor David Peter Kao

University of Colorado Anschutz Medical Campus, Aurora (United States of America)
0 follower

9 more presentations in this session

Granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up- FINAL RESULTS

Speaker: Doctor D. D'Amario (Novara, IT)

Access
Abstract
Thumbnail

Feasibility and benefit of neurohumoral blocker uptitration following cardiac resynchronization therapy

Speaker: Doctor P. Martens (Genk, BE)

Access
Abstract
Slides
Thumbnail

Relation of biological and functional LV remodeling to obstruction in hypertrophic cardiomyopathy. A rest and exercise echocardiographic study with longitudinal strain measurement

Speaker: Professor J. Trochu (Nantes, FR)

Access
Abstract
Thumbnail

Early phase 99Tc-HMDP scintigraphy: a rapid and reliable technique for the diagnosis and typing of cardiac amyloidosis

Speaker: Professor T. Damy (Creteil, FR)

Access
Abstract
Thumbnail

Less invasive ventricular reshaping provides sustained reduction of heart failure symptoms

Speaker: Doctor M. Biffi (Bologna, IT)

Access
Abstract
Thumbnail

Access the full session

Moderated Poster session 6 - Therapy

Speakers: Associate Professor D. Kao, Doctor D. D'Amario, Doctor P. Martens, Professor J. Trochu, Professor T. Damy...
Access
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb